Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125622811 | 12562281 | 1 | I | 2016 | 20160616 | 20160715 | 20160715 | EXP | FR-UCBSA-2016022782 | UCB | 66.26 | YR | F | Y | 0.00000 | 20160624 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125622811 | 12562281 | 1 | SS | Diffu-K | POTASSIUM CHLORIDE | 1 | Oral | 2 DF, 3X/DAY (TID) | U | U | 0 | 2 | DF | PROLONGED-RELEASE CAPSULE, HARD | TID | ||||
| 125622811 | 12562281 | 2 | PS | KEPPRA | LEVETIRACETAM | 1 | Oral | 500 MG, 2X/DAY (BID) | U | U | 21035 | 500 | MG | FILM-COATED TABLET | BID | ||||
| 125622811 | 12562281 | 3 | SS | QUETIAPINE FUMARATE. | QUETIAPINE FUMARATE | 1 | 50 MG, UNK | U | U | 0 | 50 | MG | PROLONGED-RELEASE TABLET | ||||||
| 125622811 | 12562281 | 4 | SS | QUETIAPINE FUMARATE. | QUETIAPINE FUMARATE | 1 | Oral | 400 MG, ONCE DAILY (QD) | U | U | 0 | 400 | MG | PROLONGED-RELEASE TABLET | QD | ||||
| 125622811 | 12562281 | 5 | SS | Nordazepam | NORDAZEPAM | 1 | U | U | 0 | ||||||||||
| 125622811 | 12562281 | 6 | SS | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | 50 MG, 2X/DAY (BID) | U | U | 0 | 50 | MG | TABLET | BID | ||||
| 125622811 | 12562281 | 7 | SS | ACUPAN | NEFOPAM HYDROCHLORIDE | 1 | 20 MG, 3X/DAY (TID) | U | U | 0 | 20 | MG | TABLET | TID | |||||
| 125622811 | 12562281 | 8 | SS | Codeine | CODEINE | 1 | UNK | U | U | 0 | |||||||||
| 125622811 | 12562281 | 9 | SS | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | 0.5 MG, 3X/DAY (TID) | U | U | 0 | .5 | MG | TABLET | TID | ||||
| 125622811 | 12562281 | 10 | SS | LYRICA | PREGABALIN | 1 | Oral | 25 MG, ONCE DAILY (QD) | U | U | 0 | 25 | MG | QD | |||||
| 125622811 | 12562281 | 11 | C | LIDOCAINE. | LIDOCAINE | 1 | UNK | U | 0 | ||||||||||
| 125622811 | 12562281 | 12 | C | DAFALGAN | ACETAMINOPHEN | 1 | Oral | 500 MG, 1 TABLET IN THE MORNING, 1 AT NOON, 2 IN THE EVENING | U | 0 | CAPSULE | ||||||||
| 125622811 | 12562281 | 13 | C | Spasfon | PHLOROGLUCINOL | 1 | 2 TABLETS / 3 DAY | U | 0 | ||||||||||
| 125622811 | 12562281 | 14 | C | LOVENOX | ENOXAPARIN SODIUM | 1 | 0.6 MG, ONCE DAILY (QD) | U | 0 | .6 | MG | CUTANEOUS SOLUTION | QD | ||||||
| 125622811 | 12562281 | 15 | C | Betneval | BETAMETHASONE VALERATE | 1 | Cutaneous | 0.1%, APPLIED 2/DAY | U | 0 | CREAM | BID | |||||||
| 125622811 | 12562281 | 16 | C | Cerulyse | 2 | INTRA-AURAL | 5 % ONCE PER DAY | U | 0 | EAR DROPS | QD | ||||||||
| 125622811 | 12562281 | 17 | C | FUNGIZONE | AMPHOTERICIN B | 1 | Oral | UNK | U | 0 | BID | ||||||||
| 125622811 | 12562281 | 18 | C | FRESUBIN | AMINO ACIDSDEXTROSEELECTROLYTES NOSSOYBEAN OILVITAMINS | 1 | 500 CC /DAY | U | 0 | ||||||||||
| 125622811 | 12562281 | 19 | C | Morphine | MORPHINE | 1 | UNK | U | 0 | ||||||||||
| 125622811 | 12562281 | 20 | C | NARCAN | NALOXONE HYDROCHLORIDE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125622811 | 12562281 | 1 | Product used for unknown indication |
| 125622811 | 12562281 | 2 | Product used for unknown indication |
| 125622811 | 12562281 | 3 | Depression |
| 125622811 | 12562281 | 5 | Product used for unknown indication |
| 125622811 | 12562281 | 6 | Product used for unknown indication |
| 125622811 | 12562281 | 7 | Product used for unknown indication |
| 125622811 | 12562281 | 8 | Product used for unknown indication |
| 125622811 | 12562281 | 9 | Product used for unknown indication |
| 125622811 | 12562281 | 10 | Product used for unknown indication |
| 125622811 | 12562281 | 11 | Product used for unknown indication |
| 125622811 | 12562281 | 12 | Product used for unknown indication |
| 125622811 | 12562281 | 13 | Product used for unknown indication |
| 125622811 | 12562281 | 14 | Product used for unknown indication |
| 125622811 | 12562281 | 15 | Product used for unknown indication |
| 125622811 | 12562281 | 16 | Product used for unknown indication |
| 125622811 | 12562281 | 18 | Product used for unknown indication |
| 125622811 | 12562281 | 19 | Product used for unknown indication |
| 125622811 | 12562281 | 20 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125622811 | 12562281 | OT |
| 125622811 | 12562281 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125622811 | 12562281 | Coma | |
| 125622811 | 12562281 | Drug level increased | |
| 125622811 | 12562281 | Epilepsy | |
| 125622811 | 12562281 | Miosis | |
| 125622811 | 12562281 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |